Skip to main content

Cardiovascular disease

Cardiovascular disease

08-14-2019 | Gestational diabetes | News

Metformin exposure during pregnancy may impact postnatal growth trajectory

Infants born to mothers with gestational diabetes treated with metformin have lower birthweight, but experience accelerated postnatal growth and have higher BMI in childhood, compared with those whose mothers were treated with insulin, suggest findings from a meta-analysis.

Obesity surgery

10-16-2018 | Metabolic surgery | medwireNews | News

Marked reduction in vascular events in diabetes patients after bariatric surgery

An observational study published in JAMA demonstrates a substantial reduction in the risk for hard cardiovascular endpoints in obese patients with type 2 diabetes who have undergone bariatric surgery.

08-30-2018 | Obesity | Review | Article

The impact of childhood and adolescent obesity on cardiovascular risk in adulthood: A systematic review

Sommer A, Twig G. Curr Diab Rep 2018; 18: 91. doi: 10.1007/s11892-018-1062-9

Heartbeat

08-26-2018 | Lorcaserin | Highlight | News

Neutral cardiovascular safety for lorcaserin in CAMELLIA-TIMI 61

The weight-loss medication lorcaserin neither increases nor reduces cardiovascular risk, report the CAMELLIA–TIMI 61 investigators.

06-27-2018 | Metformin | Article

Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan

Matsuura N et al. Diabetol Int 2018. doi: 10.1007/s13340-018-0361-3

06-22-2018 | Monogenic diabetes | Review | Article

Advances in the genetics of youth-onset type 2 diabetes

Todd JN, Srinivasan S, Pollin TI. Curr Diab Rep 2018; 18: 57. doi: 10.1007/s11892-018-1025-1

06-21-2018 | Pathophysiology | Review | Article

The gut microbiome as a target for the treatment of type 2 diabetes

Aydin Ö, Nieuwdorp M, Gerdes V. Curr Diab Rep 2018; 18: 55. doi: 10.1007/s11892-018-1020-6

06-08-2018 | Cardiovascular disorders | Review | Article

Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007–2017

Einarson TR et al. Cardiovasc Diabetol 2018; 17: 83. doi: 10.1186/s12933-018-0728-6

06-05-2018 | Cardiovascular outcomes | Article

Sex-specific associations between adolescent categories of BMI with cardiovascular and non-cardiovascular mortality in midlife

Furer A et al. Cardiovasc Diabetol 2018; 17: 80. doi: 10.1186/s12933-018-0727-7

06-04-2018 | Pediatrics | Review | Article

Identifying prediabetes and type 2 diabetes in asymptomatic youth: Should HbA1c be used as a diagnostic approach?

Vajravelu ME, Lee JM. Curr Diab Rep 2018; 18: 43. doi: 10.1007/s11892-018-1012-6

06-01-2018 | Obesity | Article

Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: A longitudinal cohort study

Adjah Owusu ES et al. Nutr Diabetes 2018; 8: 37. doi: 10.1038/s41387-018-0042-0

Chocolate

05-24-2018 | Diet | Article

Intake of cocoa products and risk of type-2 diabetes: The multiethnic cohort

Maskarinec G et al. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0188-9

05-22-2018 | Cardiovascular disorders | Article

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes

Matsutani D et al. Cardiovasc Diabetol 2018; 17: 73. doi: 10.1186/s12933-018-0717-9

New Content Item

05-31-2018 | Obesity | Highlight | News

Yet more evidence against metabolically healthy obesity

Another two large studies have demonstrated that people who appear to be in good health despite being obese do not remain so for long.

05-19-2018 | Risk factors | Review | Article

Prioritising risk factors for type 2 diabetes: Causal inference through genetic approaches

Wittemans LBL, Lotta LA, Langenberg C. Curr Diab Rep 2018; 18: 40. doi: 10.1007/s11892-018-1009-1